Abstract:Inhaled medication is the cornerstone in the treatment of patients across a spectrum of respiratory diseases including asthma and chronic obstructive pulmonary disease. The benefits of inhaled therapy have long been recognised but the most important innovations have occurred over the past 60 years, beginning with the invention of the pressurised metered dose inhaler. However, despite over 230 different device and drug combinations currently being available, disease control is far from perfect. Here we look at how innovation in inhaler design may improve treatments for respiratory diseases and how new formulations may lead to treatments for diseases beyond the lungs. We look at the three main areas where innovation in inhaled therapy is most likely to occur: 1) device engineering and design; 2) chemistry and formulations; and 3) digital technology associated with inhalers. Inhaler design has improved significantly but considerable challenges still remain in order to continually innovate and improve targeted drug delivery to the lungs. Healthcare professionals want see innovations that motivate their patients to achieve their goal of improving their health, through better adherence to treatment. Patients want devices that are easy to use and to see that their efforts are rewarded by improvements in their condition. Key points The dictionary definition of innovation is the introduction of new things, ideas or ways of doing something. We show how this definition can be applied to inhaled therapy. We take a look at the past to see what drove innovation in inhaler design and how this has led to the current devices. We look at the current drivers of innovation in engineering, chemistry and digital technology and predict how this may translate to new devices. Can innovation help the healthcare professional manage their patients better? What does the patient expect from innovation in their device? Educational aims To understand the importance of inhaled medication in the treatment of lung diseases. To understand how innovation has helped advance some of the devices patients use today from basic and inefficient designs. To understand the obstacles that prevent patients from receiving optimal treatment from their inhalers. To understand how innovation in inhaler design can lead to improved treatment for patients and widen the range of diseases that can be treated via the inhaled route.

A perspective current and past modes of inhalation therapy

Advances in the Discovery of Novel Inhaled PI3K Inhibitors for the Treatment of Asthma

Inhaled Medicines: Past, Present, and Future

Currently Available Inhaled Therapies in Asthma and Advances in Drug Delivery and Devices

Dry Powder Inhalers: A Focus on Advancements in Novel Drug Delivery Systems

Inhaled drug delivery: Past, present, and future

Inhaled Antibiotic Therapy in Chronic Respiratory Diseases

An evolving perspective on novel modified release drug delivery systems for inhalational therapy

Drug combinations for inhalation: Current products and future development addressing disease control and patient compliance

Nebulized Therapies in COPD: Past, Present, and the Future

Is there room for further innovation in inhaled therapy for airways disease?

Novel drug targets for asthma and COPD: lessons learned from in vitro and in vivo models

Real-World Use of Inhaled COPD Medications: the Good, the Bad, the Ugly

Current and novel bronchodilators in respiratory disease

Advancing Treatment Strategies: A Comprehensive Review of Drug Delivery Innovations for Chronic Inflammatory Respiratory Diseases

The Role of Pulmonary Drug Delivery in Modern Therapeutics: An Overview

Nanoparticle-Based Drug Delivery Systems in Inhaled Therapy: Improving Respiratory Medicine

New Advances and Potential Therapies for the Treatment of Asthma

Pharmacology and Therapeutics of Bronchodilators Revisited

Recent Development of Drug Delivery Systems for the Treatment of Asthma and Related Disorders

Reshaping respiratory care: potential advances in inhaled pharmacotherapy in asthma